Edition:
United Kingdom

China Grand Pharmaceutical and Healthcare Holdings Ltd (0512.HK)

0512.HK on Hong Kong Stock

4.48HKD
24 Jun 2019
Change (% chg)

HK$0.03 (+0.67%)
Prev Close
HK$4.45
Open
HK$4.45
Day's High
HK$4.58
Day's Low
HK$4.40
Volume
476,000
Avg. Vol
1,985,676
52-wk High
HK$5.95
52-wk Low
HK$3.26

Latest Key Developments (Source: Significant Developments)

China Grand Pharmaceutical & Healthcare Says Vigabatrin Tablet To Be Included In Priority Review & Approval List
Wednesday, 27 Mar 2019 

March 27 (Reuters) - China Grand Pharmaceutical and Healthcare Holdings Ltd <0512.HK>::VIGABATRIN TABLET IS PROPOSED TO BE INCLUDED IN PRIORITY REVIEW AND APPROVAL LIST.CHINA GRAND PHARMACEUTICAL AND HEALTHCARE - DRUG INCLUDED DUE TO ITS COMPLIANCE WITH FORMER CHINA FOOD AND DRUG ADMINISTRATION.CHINA GRAND PHARMACEUTICAL AND HEALTHCARE -DRUG COMPLIES WITH FORMER CFDA'S OPINIONS ON IMPLEMENTATION OF PRIORITY REVIEW,APPROVAL OF DRUG INNOVATION.  Full Article

China Grand Pharmaceutical And Healthcare Announces Termination Of Acquisition
Friday, 28 Dec 2018 

Dec 28 (Reuters) - China Grand Pharmaceutical and Healthcare Holdings Ltd <0512.HK>::CHINA GRAND PHARMACEUTICAL AND HEALTHCARE ANNOUNCES TERMINATION OF ACQUISITION OF SHANGHAI WINGUIDE HUANGPU PHARMACEUTICAL CO LTD.  Full Article

China Grand Pharmaceutical And Healthcare Announces Completion Of Sirtex Medical Acquisition
Thursday, 20 Sep 2018 

Sept 20 (Reuters) - China Grand Pharmaceutical and Healthcare Holdings Ltd <0512.HK>::CHINA GRAND PHARMACEUTICAL AND HEALTHCARE ANNOUNCES COMPLETION OF ACQUISITION OF SIRTEX MEDICAL LIMITED.GROUP HAS BECOME INDIRECT OWNER OF 49% EQUITY INTERESTS OF SIRTEX.  Full Article

China Grand Pharmaceutical And Healthcare Acquires Shanghai Winguide Huangpu Pharmaceutical Co
Thursday, 31 May 2018 

June 1 (Reuters) - China Grand Pharmaceutical and Healthcare Holdings Ltd <0512.HK>::ACQUISITION OF 100% OF EQUITY INTERESTS IN SHANGHAI WINGUIDE HUANGPU PHARMACEUTICAL CO.CHINA GRAND PHARMACEUTICAL AND HEALTHCARE ANNOUNCES ACQUISITION OF 100% OF STAKE IN SHANGHAI WINGUIDE HUANGPU PHARMACEUTICAL CO FOR RMB1,551.3 MILLION.WINGUIDE FAR EAST SELLS SHANGHAI WINGUIDE HUANGPU PHARMACEUTICAL CO TO GRAND PHARMACEUTICAL (CHINA) CO.  Full Article

China Grand Pharmaceutical And Healthcare Posts FY‍ Profit Attributable Of HK$460.8 Mln
Thursday, 15 Mar 2018 

March 15 (Reuters) - China Grand Pharmaceutical And Healthcare Holdings Ltd <0512.HK>::FY‍ REVENUE HK$4.77 BILLION VERSUS HK$3.70 BILLION.‍FY PROFIT ATTRIBUTABLE HK$460.8 MILLION VERSUS HK$269.1 MILLION.  Full Article

China Grand Pharmaceutical And Healthcare Gets ‍Drug Clinical Trial Approval Document From China FDA For Products
Thursday, 28 Dec 2017 

Dec 28 (Reuters) - China Grand Pharmaceutical And Healthcare Holdings Ltd <0512.HK>::CHINA GRAND PHARMACEUTICAL AND HEALTHCARE HOLDINGS- ‍"BIMATOPROST OPHTHALMIC SOLUTION" OBTAINED DRUG CLINICAL TRIAL APPROVAL DOCUMENT FROM CHINA FDA.  Full Article

China Grand Pharmaceutical and Healthcare announces ‍subscription of shares of Conavi Medical
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - China Grand Pharmaceutical And Healthcare Holdings Ltd <0512.HK>::Announces ‍subscription of shares of medical devices company in Canada​.JV will subscribe to 1 million preferred shares of Conavi Medical for US$7.5 million​.  Full Article

China Grand Pharmaceutical and Healthcare Holdings says to establish JV co
Monday, 13 Nov 2017 

Nov 13 (Reuters) - China Grand Pharmaceutical And Healthcare Holdings Ltd <0512.HK>:Co and East Ocean Capital agreed to establish JV in Hong Kong.‍Total investment in JV will be about US$15 million​.  Full Article

China Grand Pharmaceutical and Healthcare announces increase in shareholding in co by controlling shareholder
Wednesday, 27 Sep 2017 

Sept 27 (Reuters) - China Grand Pharmaceutical and Healthcare Holdings Ltd <0512.HK>:Increase in shareholding in the company by the controlling shareholder .Immediately after acquisition, HU is deemed to be interested in about 67.00% of issued shares.Shanghai Grand Financial Investment Co obtained interests in aggregate 9.1 million shares in co for HK$20.7 million between 8 May to 26 Sept.  Full Article

China Grand Pharmaceutical And Healthcare says HY turnover HK$2.28 bln
Thursday, 17 Aug 2017 

Aug 17 (Reuters) - China Grand Pharmaceutical And Healthcare Holdings Ltd <0512.HK> : :Hy turnover hk$2.28 billion versus hk$1.78 billion.HY profit for period attributable hk$205.9 million versus hk$110.8 million.  Full Article